Clipping of news on Brazilian Culture, Law and Citizenship
 


Consumer News

Pricing remedies black and red stripe may fall 11%, industry estimates

30/06/2014

This article was translated by an automatic translation system, and was therefore not reviewed by people.

 


 

transparent image




Aline Leal - Brazil Agency reporter Edition: Carolina Pimentel

The government today (27) published the updated list of substances used in the production of medicines of black and red stripe, and are exempt from PIS / COFINS. With the exemption, the expectation of the pharmaceutical industry is down by 11% in the prices of these medicines. The last time the government updated the list, which now has 1,643 items, was in 2007.

The estimated reduction is the Association of the Pharmaceutical Industry Research (Interfarma). Among the products are the remedies for the treatment of cancer, chronic use, such as hypertension, diabetes and asthma. Altogether, the list published in the Official Gazette brings 174 items that have the exemption. The substances are part of the composition of medicines black, red stripe and some products for hemodialysis and tube feeding. With the update, 75.4% of the medicines sold in the country be exempt from PIS / COFINS, according to the Ministry of Health

Fernando Sampaio, Interfarma director, explains that the Law 10.147/00 establishes that all products with the stripe can have the exemption, but the fiscal stimulus occurs only when the remedy has the active ingredients listed in the decree.

"Today, more than 65% of the revenues of the pharmaceutical industry are already exempt. Products are for the most serious diseases, chronic diseases, contagious diseases. Those who are not are non-prescription, and for less severe diseases, eg erectile dysfunction, obesity, "Sampaio said, adding that" the ideal is that the benefit was for all products with stripe or that every year the government publish a list ".

According to the Ministry of Health, the selection of exempted substances considers whether the remedy is for chronic and degenerative diseases; it meets health programs instituted by the government through public policy and if the product is essential for the population. To have the incentive, the drugs should be subject to medical prescription, be identified by red or black stripe and intended for sale in the domestic market.


Source: Agencia Brazil

Our news are taken in full from our partner sites. For this reason, we can not change their content even in cases of typos.
transparent image

This article was translated by an automatic translation system, and was therefore not reviewed by people.

Important:
The JurisWay site does not interfere in the work provided by doctrine, why only reflect the opinions, ideas and concepts of their authors.


  Subjects list
 
  Copyright (c) 2006-2009. JurisWay - All rights reserved.